Clinical Trials Directory

We are doing this study to test the feasibility and acceptability of an experimental communication device. This device was invented by a team from the Duke Pratt School of Engineering and is intended to help people with ALS and those who help take care of them.

We are doing this study to learn how we can help and improve care for patients that have had a transplant.

We are doing this study to find out if the combination of an investigational peptide (small protein) vaccine developed at Duke and a drug called vorasidenib is a safe and effective option for people with recurrent or progressive IDH1 mutant lower grade gliomas (brain tumors).

We are doing this study to find out the most preferred method among lung cancer patients for being connected to remote patient monitoring (RPM) devices. RPM devices are instruments that a patient can use to measure their own weight and vital signs. We want to find out if patients have an easier, more efficient time setting up these devices by using a virtual interface or with the assistance of a human agent.

We are doing this study to find out the practicality of using a new program called ViSPad on an electronic tablet. We want to know if this program can help reduce anxiety for cancer patients who are having imaging scans done (for example, MRI).

We are doing this study to find out if an experimental drug combination of vorasidenib and temozolomide (the study drugs) is a safe and effective option for people who have glioma with IDH1 or IDH2 mutations.

We are doing this study is to see if we can predict carotid artery function using wearable technology (for example, a FitBit®).

We are doing this study to develop an algorithm to help make accurate decisions about how to manage traumatic wounds. We hope this tool will help us determine the ideal time to use surgery to close major wounds in a way that will best promote healing.